Search

Your search keyword '"Jacqz-Aigrain, Evelyne"' showing total 32 results
Start Over Author "Jacqz-Aigrain, Evelyne" Publisher elsevier bv
32 results on '"Jacqz-Aigrain, Evelyne"'

1. Modalités pratiques de prise en charge en cours de traitement d’entretien des leucémies aiguës lymphoblastiques pédiatriques : recommandations du Comité leucémies de la Société française de lutte contre les cancers et les leucémies de l’enfant et de l’adolescent (SFCE)

Author

Saultier, Paul, primary, Simonin, Mathieu, additional, Beaumais, Tiphaine Adam de, additional, Rialland, Fanny, additional, Alby-Laurent, Fanny, additional, Lubnau, Marion, additional, Desplantes, Claire, additional, Jacqz-Aigrain, Evelyne, additional, Rohrlich, Pierre, additional, Reguerre, Yves, additional, Rabian, Florence, additional, Sirvent, Nicolas, additional, Plat, Geneviève Willson, additional, and Petit, Arnaud, additional

Published
2022
Full Text
View/download PDF

2. Agreement between a regional pharmacovigilance centre and an adjudication committee regarding adverse drug reactions on a cohort of hospitalised children

Author

Pages, Nicolas, primary, Bounabi, Anissa, additional, Boussaha, Inesse, additional, Ndiaye, Marietou, additional, Portefaix, Aurélie, additional, Simeon, Gaelle, additional, Guy, Claire, additional, Stagnara, Jean, additional, Paret, Nathalie, additional, Vial, Thierry, additional, Eftekhari, Pirayeh, additional, Floret, Daniel, additional, Gajdos, Vincent, additional, Langhendries, Jean-Paul, additional, Bleyzac, Nathalie, additional, Alberti, Corinne, additional, Jacqz-Aigrain, Evelyne, additional, Nguyen, Kim An, additional, and Kassai, Behrouz, additional

Published
2022
Full Text
View/download PDF

3. Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial

Author

Hill, Louise F, primary, Clements, Michelle N, additional, Turner, Mark A, additional, Donà, Daniele, additional, Lutsar, Irja, additional, Jacqz-Aigrain, Evelyne, additional, Heath, Paul T, additional, Roilides, Emmanuel, additional, Rawcliffe, Louise, additional, Alonso-Diaz, Clara, additional, Baraldi, Eugenio, additional, Dotta, Andrea, additional, Ilmoja, Mari-Liis, additional, Mahaveer, Ajit, additional, Metsvaht, Tuuli, additional, Mitsiakos, George, additional, Papaevangelou, Vassiliki, additional, Sarafidis, Kosmas, additional, Walker, A Sarah, additional, Sharland, Michael, additional, Hill, Louise F, additional, Clements, Michelle, additional, Bafadal, Basma, additional, Alarcon Allen, Ana, additional, Anatolitou, Fani, additional, Del Vecchio, Antonio, additional, Giuffrè, Mario, additional, Karachristou, Korina, additional, Manzoni, Paolo, additional, Martinelli, Stefano, additional, Moriarty, Paul, additional, Nika, Angeliki, additional, Papaevangelou, Vana, additional, Roehr, Charles, additional, Sanchez Alcobendas, Laura, additional, Siahanidou, Tania, additional, Tzialla, Chryssoula, additional, Bonadies, Luca, additional, Booth, Nicola, additional, Catalina Morales-Betancourt, Paola, additional, Cordeiro, Malaika, additional, de Alba Romero, Concha, additional, de la Cruz, Javier, additional, De Luca, Maia, additional, Farina, Daniele, additional, Franco, Caterina, additional, Gialamprinou, Dimitra, additional, Hallik, Maarja, additional, Ilardi, Laura, additional, Insinga, Vincenzo, additional, Iosifidis, Elias, additional, Kalamees, Riste, additional, Kontou, Angeliki, additional, Molnar, Zoltan, additional, Nikaina, Eirini, additional, Petropoulou, Chryssoula, additional, Reyné, Mar, additional, Tataropoulou, Kassandra, additional, Triantafyllidou, Pinelopi, additional, Vontzalidis, Adamantios, additional, and Sharland, Mike, additional

Published
2022
Full Text
View/download PDF

4. Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol

Author

Nguyen, Kim An, primary, Mimouni, Yanis, additional, Jaberi, Elham, additional, Paret, Nathalie, additional, Boussaha, Inesse, additional, Vial, Thierry, additional, Jacqz-Aigrain, Evelyne, additional, Alberti, Corinne, additional, Guittard, Laure, additional, Remontet, Laurent, additional, Roche, Laurent, additional, Bossard, Nadine, additional, and Kassai, Behrouz, additional

Published
2021
Full Text
View/download PDF

5. Outcome associated with prescription of cardiac rehabilitation according to predicted risk after acute myocardial infarction: Insights from the FAST-MI registries

Author

Debiec, Hanna, Dossier, Claire, Letouzé, Eric, Gillies, Christopher, Vivarelli, Marina, Putler, Rosemary, Ars, Elisabet, Jacqz-Aigrain, Evelyne, Elie, Valery, Colucci, Manuela, Debette, Stéphanie, Amouyel, Philippe, Elalaoui, Siham, Sefiani, Abdelaziz, Dubois, Valérie, Kretzler, Matthias, Ballarin, Jose, Emma, Francesco, Sampson, Matthew, Deschênes, Georges, Ronco, Pierre, Ederhy, Stephane, Cohen, Ariel, Boccara, Franck, Aissaoui, Nadia, Elbaz, Meyer, Bonnefoy-Cudraz, Eric, Druelles, Philipe, Andrieu, Stéphane, Angoulvant, Denis, Furber, Alain, Cottin, Yves, Puymirat, Etienne, Bonaca, Marc, Iliou, Marie-Christine, Tea, Victoria, Ducrocq, Grégory, Douard, Hervé, Labrunee, Marc, Plastaras, Philoktimon, Chevallereau, Pierre, Taldir, Guillaume, Bataille, Vincent, Ferrières, Jean, Schiele, François, Simon, Tabassome, Danchin, Nicolas, Centre de Ressources Biologiques APHP-SU (PASS-CRB-APHP-SU), Unité Mixte de Service Production et Analyse de données en Sciences de la vie et en Santé (PASS), and Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
Male, Time Factors, MESH: Registries, health care facilities, manpower, and services, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Cardiac rehabilitation, 030204 cardiovascular system & hematology, MESH: Risk Assessment, MESH: Aged, 80 and over, 0302 clinical medicine, Risk Factors, MESH: Risk Factors, Medicine, Registries, MESH: Cardiac Rehabilitation, 030212 general & internal medicine, Myocardial infarction, Atherothrombotic risk stratification, Non-ST Elevated Myocardial Infarction, health care economics and organizations, Cancer, MESH: Treatment Outcome, Aged, 80 and over, MESH: Aged, education.field_of_study, MESH: Middle Aged, Framingham Risk Score, Rehabilitation, nephrotic syndrome, MESH: Polymorphism, Single Nucleotide, Hazard ratio, Score, genetic renal disease, General Medicine, Middle Aged, MESH: Recovery of Function, 3. Good health, In-hospital mortality, Treatment Outcome, Stratification risque athérothrombotique, cardiovascular system, Female, France, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, pediatrics, education, Population, Infarctus du myocarde, Acute myocardial infarction, Mortalité, MESH: Phenotype, Risk Assessment, 03 medical and health sciences, Intensive care, Internal medicine, MESH: Spain, Humans, cardiovascular diseases, Mortality, Réadaptation cardiaque, MESH: ST Elevation Myocardial Infarction, Medical prescription, Aged, focal segmental glomerulosclerosis, genome-wide association study, MESH: Humans, business.industry, MESH: Time Factors, MESH: Italy, Recovery of Function, medicine.disease, MESH: Male, MESH: Quantitative Trait Loci, MESH: Steroids, Confidence interval, MESH: France, MESH: Non-ST Elevated Myocardial Infarction, gene expression, Mortalité hospitalière, ST Elevation Myocardial Infarction, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Nephrotic Syndrome, business, MESH: Female
Abstract

Cardiac rehabilitation is strongly recommended in patients after acute myocardial infarction.To assess cardiac rehabilitation prescription after acute myocardial infarction according to predicted risk, and its association with 1-year mortality, using the FAST-MI registries.We used data from three 1-month French nationwide registries, conducted 5 years apart from 2005 to 2015, including 13130 patients with acute myocardial infarction admitted to coronary or intensive care units. Atherothrombotic risk stratification was performed using the Thrombolysis In Myocardial Infarction Risk Score for Secondary Prevention (TRS-2P). Patients were classified into three categories: Group 1 (low risk; no or one risk indicator; score of 0 or 1); Group 2 (intermediate risk; two risk indicators; score of 2); and Group 3 (high risk; at least three risk indicators; score of≥3).Among the 12291 patients, cardiac rehabilitation prescription was 43.6% (49.9% in Group 1; 43.0% in Group 2; 35.2% in Group 3). Using Cox multivariable analysis, cardiac rehabilitation prescription was associated with lower mortality at 1 year in the overall population (3.8% vs. 8.2%; hazard ratio [HR] 0.72, 95% confidence interval [CI] 0.61-0.85; P0.001). Cardiac rehabilitation was associated with improved 1-year mortality, with homogeneous relative risk reductions in low- and intermediate-risk categories (HR 0.70, 95% CI 0.51-0.94) compared with high-risk patients (HR 0.72, 95% CI 0.59-0.88). In absolute terms, however, mortality decrease associated with cardiac rehabilitation was positively correlated with risk level (Group 1, 0.9% vs. 2.4%; Group 2, 3.0% vs. 4.2%; Group 3, 10.5% vs. 17.3%).Cardiac rehabilitation prescription was inversely correlated with patient risk. A positive association between cardiac rehabilitation and 1-year survival after acute myocardial infarction was present whatever the risk level, but the greatest mortality reduction was observed in high-risk patients.

Published
2019

6. Paediatric clinical research in Europe: an insight on experts’ needs and perspectives

Author

Ruggieri, Lucia, primary, Ceci, Adriana, additional, Bartoloni, Franco, additional, Elie, Valèry, additional, Felisi, Mariagrazia, additional, Jacqz-Aigrain, Evelyne, additional, Lupo, Mariangela, additional, Malik, Salma, additional, Manfredi, Cristina, additional, Reggiardo, Giorgio, additional, Demotes, Jacques, additional, and Bonifazi, Donato, additional

Published
2021
Full Text
View/download PDF

13. Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in children

Author

Tiphaine, Adam de Beaumais, primary, Hjalgrim, Lisa Lynqsie, additional, Nersting, Jacob, additional, Breitkreutz, Joerg, additional, Nelken, Brigitte, additional, Schrappe, Martin, additional, Stanulla, Martin, additional, Thomas, Caroline, additional, Bertrand, Yves, additional, Leverger, Guy, additional, Baruchel, André, additional, Schmiegelow, Kjeld, additional, and Jacqz-Aigrain, Evelyne, additional

Published
2016
Full Text
View/download PDF

14. Safety study of Ciprofloxacin in newborn mice

Author

Bourgeois, Thomas, primary, Delezoide, Anne-Lise, additional, Zhao, Wei, additional, Guimiot, Fabien, additional, Adle-Biassette, Homa, additional, Durand, Estelle, additional, Ringot, Maud, additional, Gallego, Jorge, additional, Storme, Thomas, additional, Le Guellec, Chantal, additional, Kassaï, Behrouz, additional, Turner, Mark A., additional, Jacqz-Aigrain, Evelyne, additional, and Matrot, Boris, additional

Published
2016
Full Text
View/download PDF

15. Recruitment in pediatric clinical research was influenced by study characteristics and pediatricians' perceptions: a multicenter survey

Author

Kaguelidou, Florentia, primary, Amiel, Philippe, additional, Blachier, Audrey, additional, Iliescu, Catalina, additional, Rozé, Jean-Christophe, additional, Tsimaratos, Michel, additional, Brandt, Christian, additional, Kassai-Koupai, Behrouz, additional, Jacqz-Aigrain, Evelyne, additional, Gaultier, Claude, additional, and Alberti, Corinne, additional

Published
2013
Full Text
View/download PDF

18. Antifungal prophylaxis in neonates

Author

Manzoni, Paolo, primary, Jacqz-Aigrain, Evelyne, additional, Rizzollo, Stefano, additional, Franco, Caterina, additional, Stronati, Mauro, additional, Mostert, Michael, additional, and Farina, Daniele, additional

Published
2011
Full Text
View/download PDF

22. Méthodes de surveillance et de gestion des risques des médicaments pour la future mère, l’embryon, le fœtus et le nouveau-né

Author

Jacqz-Aigrain, Evelyne, primary, Lamarque, Véronique, additional, Autret-Leca, E., additional, Becquemont, L., additional, Boutroy, M.-J., additional, Carlier, P., additional, Castot, A., additional, Cornu, C., additional, Damase-Michel, C., additional, Demarez, J.-P., additional, Dohin, E., additional, Gersberg, M., additional, Kreft-Jais, C., additional, Le Louet, H., additional, Meillier, F., additional, Parier, J.-L., additional, Pons, G., additional, Subtil, D., additional, and Vial, T., additional

Published
2006
Full Text
View/download PDF

23. Risk Management and Monitoring Methods for the Future Mother, Embryo, Fetus, and post-natal Consequences

Author

Jacqz-Aigrain, Evelyne, primary, Lamarque, Véronique, additional, Autret-Leca, E., additional, Becquemont, L., additional, Boutroy, M.-J., additional, Carlier, P., additional, Castot, A., additional, Cornu, C., additional, Damase-Michel, C., additional, Demarez, J.-P., additional, Dohin, E., additional, Gersberg, M., additional, Kreft-Jais, C., additional, Le Louet, H., additional, Meillier, F., additional, Parier, J.-L., additional, Pons, G., additional, Subtil, D., additional, and Vial, T., additional

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results